SLC6A3 and Parkinson disease: Furthermore, studies have shown that inhibiting SIRT2 activity via miR-212-5p transfection can prevent dopaminergic neuron loss and reduce dopamine transporter (DAT), implying that miR-212-5p can control PD by targeting SIRT2 (Sun et al., 2018).